VBI Vaccines Inc. announced that it has entered into a stock purchase agreement with returning investor Brii Biosciences Limited to issue 1 common share at an issue price of $3,000,00 for the gross proceeds of $3,000,000 on July 5, 2023. The Transaction is contingent upon the closing of a concurrent underwritten public offering for aggregate gross proceeds of at least $5,000,000.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.23 HKD | -2.38% | -3.15% | -46.05% |
03-25 | Transcript : Brii Biosciences Limited, 2023 Earnings Call, Mar 25, 2024 | |
03-22 | Brii Biosciences Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
1.23 HKD | -2.38% | -3.15% | 118M | ||
0.6325 USD | +2.02% | +5.43% | 17.78M | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-46.05% | 118M | |
+5.66% | 109B | |
+11.23% | 105B | |
-0.38% | 22.25B | |
-12.15% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-10.09% | 16.85B | |
+3.33% | 13.76B | |
+36.58% | 12.46B |
- Stock Market
- Equities
- 2137 Stock
- News Brii Biosciences Limited
- VBI Vaccines Inc. announced that it expects to receive $3 million in funding from Brii Biosciences Limited